PMDA and Asia-Pacific Approval Pathways
PMDA and Asia-Pacific Approval Pathways Companion Diagnostic Approval Pathways in Japan and the Asia-Pacific Region Introduction: Why the Asia-Pacific Region Matters for CDx Developers As the pharmaceutical market continues to expand across Asia-Pacific (APAC), countries like Japan, China, South Korea, and Australia have introduced specific regulatory frameworks for companion diagnostics (CDx). For global clinical trials…